USRDS 1998 II - 1 335,014 287,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.

Slides:



Advertisements
Similar presentations
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Advertisements

Vol 2, ESRD, Ch ANNUAL DATA REPORT VOLUME 2: END-STAGE RENAL DISEASE Chapter 9: Costs of ESRD.
Chapter 3: Clinical Indicators and Preventive Care 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 2: Healthy People A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Chapter 2: Identification and Care of Patients With CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Vol 2 Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, Data Source: Reference.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Chapter i: Introduction 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Chapter 3: Morbidity & Mortality 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Haemodialysis Vascular Access: Recent Trends From ANZDATA Dr Kevan Polkinghorne Monash Medical Centre ANZSN September 2007.
Primary ESRD Modality in New ESRD Patients, * New Patients (%) *Reported on HCFA Medical Evidence Form USRDS 1999 IV -1.
Healthy People 2010 Focus Area 4
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
Chapter 2: Identification and Care of Patients With CKD 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 9: Cardiovascular Disease in Patients With ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 11: Costs of ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 14: End-of-life Care for Patients with End-Stage Renal Disease:
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 4: Vascular Access.
Chronic Kidney Disease (CKD) Healthy Kansans 2010.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Figure 9.1 Causes of death in ESRD patients,
Figure 11.1 Trends in ESRD expenditures,
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Table 6.1 Prevalent Medicare fee-for-service patient counts and spending for beneficiaries aged 65 and older, by DM, CHF, and/or CKD, 2014 U.S. Medicare.
Odd ratio of developing kidney failure figure 1
Chapter 2: Identification and Care of Patients With CKD
Mortality rates in incident ESRD patients figure 9
Volume 2: End-Stage Renal Disease
Chapter 8: Cardiovascular Disease in Patients with ESRD
2017 Annual Data Report Healthy People 2020.
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
Chapter 12: End-of-life Care for Patients with ESRD:
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
December 31st point prevalent counts by modality figure 3.1
2016 Annual Data Report, Vol 2, ESRD, Ch 4
Hospital admissions per patient, by modality figure 5
Chapter 9: Healthcare Expenditures for Persons with ESRD
2016 Annual Data Report, Vol 2, ESRD, Ch 14
Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization
2018 Annual Data Report Volume 3: Healthy People 2020
Volume 2: End-Stage Renal Disease Chapter 6: Transplantation
Volume 2: End-Stage Renal Disease
Volume 2: End-Stage Renal Disease
Chapter 2: Identification and Care of Patients with CKD
Chapter 8: Cardiovascular Disease in Patients with ESRD
Chapter 12: End-of-life Care for Patients with ESRD:
Adjusted 1st-Year Patient Death Rates by
New ESRD Patients and Main Sources
Cause Specific Death Rates for All Dialysis Patients
Reported ESRD Period and Point Prevalence,
Patient characteristics: American vs Canadian transplant patients
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Worldwide incidence of ESRD figure 12.1, per million population
Figure 9.1.a Causes of death in ESRD patients,
Chapter 2: Identification and Care of Patients with CKD
Presentation transcript:

USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported ESRD Period and Point Prevalence, Incidence, Death, and Lost-to-Followup Counts, ,348 *

USRDS 1998 II - 2 *Preliminary Reported ESRD Point Prevalence Counts by Data Source and Medicare Eligibility, Patients (1000s) Medicare Functioning Kidney Graft Medicare Dialysis USRDS Database HCFA Facility Survey Year 215, , ,443 78,810 Medicare and Non-Medicare Dialysis *

USRDS 1998 II - 3 ESRD Prevalence Rates by Year, Year Fitted Curve Actual Rates 95 % High Range 95% Low Range Rate/Million Pop./Year *Preliminary * 1996 estimate is inflated by 1% and is denoted by “O”

USRDS 1998 II - 4 ESRD Incidence Rates by Year, Year Fitted Curve Actual Rates 95 % High Range 95% Low Range Rate/Million Pop./Year 1996 estimate is inflated by 5% and is denoted by “O” *Preliminary *

USRDS 1998 II - 5 Increases in Incident Dialysis Patient Counts According to Two Sources, % Increase / Year Year increase (Medicare only prior to 1994) *1996 data preliminary *

USRDS 1998 II - 6 ESRD Incidence Rates* by Age, Age 0-19 Age Age Age 75+ Age Rate/Million Pop./Year * Adjusted for sex and race ** Preliminary ** Year

USRDS 1998 II - 7 Mean Age at Incidence for All ESRD Patients by Race, Mean Age (years) Year of Incidence Total Asian Black White Native Am * Preliminary *

USRDS 1998 II - 8 ESRD Incidence Rates* and Annualized Change by Race, Rate per Million Pop/Year ( )Change/Year (%) ( vs ) *Adjusted for age and sex

USRDS 1998 II - 9 Rate/Million Pop./Year Treated Medicare ESRD Incidence Rates* by Primary Diagnosis, Primary Disease Causing ESRD Overall Rate=263 *Adjusted for age, sex, and race

USRDS 1998 II - 10 Annualized Change in Medicare ESRD Incidence Rates by Primary Diagnosis, * Primary Disease Causing ESRD Change/Year (%) *Annualized vs % Overall Change Missing